Moderna, Inc.
General ticker "MRNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.0B (TTM average)
Moderna, Inc. follows the US Stock Market performance with the rate: 2.8%.
Estimated limits based on current volatility of 2.4%: low 24.37$, high 25.57$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 5800 as of 2024
- US accounted for 53.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Managing rapid expansion, Geopolitical risks, Internal control weaknesses, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [24.18$, 65.48$]
- 2025-12-31 to 2026-12-31 estimated range: [24.17$, 60.89$]
Financial Metrics affecting the MRNA estimates:
- Negative: with PPE of -4.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -19.63 <= 0.33
- Positive: Shareholder equity ratio, % of 77.08 > 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 12.74 > -0.66
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term MRNA quotes
Long-term MRNA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $19,263.00MM | $6,848.00MM | $3,236.00MM |
| Operating Expenses | $9,843.00MM | $11,087.00MM | $7,181.00MM |
| Operating Income | $9,420.00MM | $-4,239.00MM | $-3,945.00MM |
| Non-Operating Income | $155.00MM | $297.00MM | $338.00MM |
| R&D Expense | $3,295.00MM | $4,845.00MM | $4,543.00MM |
| Income(Loss) | $9,575.00MM | $-3,942.00MM | $-3,607.00MM |
| Taxes | $1,213.00MM | $772.00MM | $-46.00MM |
| Profit(Loss)* | $8,362.00MM | $-4,714.00MM | $-3,561.00MM |
| Stockholders Equity | $19,123.00MM | $13,854.00MM | $10,901.00MM |
| Inventory | $949.00MM | $202.00MM | $117.00MM |
| Assets | $25,858.00MM | $18,426.00MM | $14,142.00MM |
| Operating Cash Flow | $4,981.00MM | $-3,118.00MM | $-3,004.00MM |
| Capital expenditure | $400.00MM | $707.00MM | $1,051.00MM |
| Investing Cash Flow | $-5,176.00MM | $4,206.00MM | $1,949.00MM |
| Financing Cash Flow | $-3,448.00MM | $-1,377.00MM | $56.00MM |
| Earnings Per Share** | $21.22 | $-12.34 | $-9.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.